NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against GoHealth, Inc. (NASDAQ:GOCO) and Abacus Global Management, Inc. (NASDAQ:ABL). Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices. Additional information about each case can be found at the link provided. GoHealth, Inc. (NASDAQ:GOCO) On May 1, 2025, t ...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. Red Cat Holdings, Inc. (NASDAQ: RCAT) Class Period: M ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Vestis To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Vestis between May 2, 2024 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) - ...

Advances in artificial intelligence (AI) are rapidly transforming the global economy by automating complex workflows and delivering predictive insights that unlock unprecedented levels of productivity.BigBear.ai (BBAI 0.78%) is a prime example of an emerging leader in the field that deserves a closer look by investors. The technology sector small-cap is developing AI-powered decision intelligence solutions positioned to capitalize on a significant long-term growth opportunity.Does a promising outlook for Bi ...

Do we need to fear fallout from the Trump/Musk feud?… Luke Lango’s latest agentic AI research… how Nvidia proved me wrong… making double-digit returns in today’s volatility with Jeff ClarkVIEW IN BROWSERThe “big, beautiful breakup” between President Donald Trump and Elon Musk that began late last week and continued over the weekend is far more gossip than news.But there are some investment implications:Tesla’s stock: It tanked 15% last Thursday but popped nearly 4% on Friday – great for nimble tradersEV tax ...

Monday’s news that Warner Bros. Discovery is splitting into two companies – one consisting of studios and streaming, the other linear TV networks – has cued up Hollywood’s latest succession drama. David Zaslav, having steered WBD as CEO since the 2022 close of the $43 billion merger of Discovery (which he formerly ran) and WarnerMedia, is slated to be CEO of the “S&S” (studios and streamers) entity. Gunnar Wiedenfels, Warner Discovery’s CFO, who held the same post at Discovery and has a pure finance backgr ...

Core Points - Cordoba Minerals Corp. held its Annual General Meeting of Shareholders on June 9, 2025, where all nominated directors were elected [1] - Shareholders voted overwhelmingly in favor of the re-appointment of Deloitte LLP as the company's auditors for the upcoming year [2] - The company's stock option plan was re-approved, allowing for the issuance of shares not exceeding 10% of the company's issued and outstanding shares, pending final approval from the TSX Venture Exchange [3] Company Overview - Cordoba Minerals Corp. is focused on the exploration, development, and acquisition of copper and gold projects, including the Alacran Project in Colombia and a 51% interest in the Perseverance Copper Project in Arizona, USA [4]

Core Insights - Apple's annual developer conference did not feature major announcements, lacking the excitement seen in previous years like the Vision Pro reveal in 2023 [1] - A significant software update called Liquid Glass will be introduced later this year, affecting the design across all major Apple devices [2] - This marks the first major redesign of the iPhone operating system since 2013, with a new lock screen design and fluid animations [3] Financial Market Reaction - Wall Street reacted negatively to the conference, with Apple's stock declining by 1.2% on the day of the event [4] - Investors are urging Apple to enhance its artificial intelligence strategy to compete with leading models from Google and OpenAI [4] - Analyst David Vogt from UBS noted that many AI features announced were incremental and already available through competitors [4] AI Development Status - Apple previously announced Apple Intelligence as a response to ChatGPT, featuring a more personal Siri, but has delayed its rollout [5] - The company has not provided updates on the timing of this feature since its delay in March [5] - Apple's software chief Craig Federighi emphasized the need for more time to meet quality standards, reiterating a timeline of "the coming year" for the feature [6]

Core Insights - Ascentage Pharma announced that 13 studies of its key assets will be presented at the 2025 European Hematology Association Annual Congress in Milan, Italy, from June 12-15, 2025 [1][2] Company Overview - Ascentage Pharma is a global biopharmaceutical company focused on addressing unmet medical needs in cancers, with a pipeline that includes innovative drug candidates targeting key proteins in the apoptotic pathway and next-generation kinase inhibitors [8][9] Key Assets and Studies - The lead asset, olverembatinib, is a third-generation BCR-ABL1 inhibitor approved in China for treating patients with chronic myeloid leukemia (CML) and is currently undergoing global registrational Phase III trials for CML and newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) patients [9][10] - The second lead asset, lisaftoclax, is a novel Bcl-2 inhibitor for various hematologic malignancies, with an NDA accepted for priority review in China [10] - Studies to be presented include: - Oral presentation on integrating genomic and transcriptomic insights for predicting responses in patients with chronic myeloid leukemia (CML) [3] - Poster presentations on the combination of olverembatinib with other therapies for newly diagnosed Ph+ acute lymphoblastic leukemia [4][5] - Online publications covering various studies on olverembatinib's efficacy and safety in different patient populations [6] Event Significance - The EHA Annual Congress is the largest gathering of the hematology community in Europe, attracting over 10,000 attendees from more than 100 countries, showcasing cutting-edge research and clinical results [2]

Core Points - The Company announced an extension of the Expiration Date for its cash tender offer to purchase Landsea Homes' outstanding 8.875% Senior Notes due 2029 and to solicit consents from holders of the Notes [1][2] Group 1: Tender Offer Details - The Expiration Date has been extended from June 11, 2025, to June 23, 2025, unless further extended or terminated [2] - As of the current date, the Company received tenders and consents from holders amounting to $293,848,000, which is approximately 97.95% of the total outstanding principal amount of the Notes [3] - The consideration payable for the Notes includes $994.38 for each $1,000 in principal amount, with an Early Participation Premium of $50, leading to a total consideration of $1,044.38 for those who tendered by the Early Tender Date [3][4] Group 2: Conditions and Amendments - The consummation of the Tender Offer is subject to certain conditions, including the completion of a Merger and a financing condition [7] - The Company intends to extend the Expiration Date until the closing of the Merger, and it reserves the right to waive any conditions to the Tender Offer [7] - A supplemental indenture was entered into on May 29, 2025, to effect proposed amendments, which will only become operative if a majority of the Notes are accepted for purchase [7][8]